A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma

Published:2012-09 Issue:3 Volume:104 Page:286-293
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Peng Gang,Wang Tao,Yang Kun-yu,Zhang Sheng,Zhang Tao,Li Qin,Han Jun,Wu Gang

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference44 articles.

1. Clinical significance of cranial nerve deficit in the therapy of nasopharyngeal carcinoma;Chen;Br J Radiol,1989

2. Presenting signs and symptoms of nasopharyngeal carcinoma;Epstein;Oral Surg Oral Med Oral Pathol,1993

3. Nasopharyngeal carcinoma: methods of presentation;Skinner;Ear Nose Throat J,1990

4. Nasopharyngeal carcinoma: the role of the dentist in assessment, early diagnosis and care before and after cancer therapy;Mackie;Oral Oncol,2000

5. Intensity-modulated radiation therapy for head and neck carcinoma;Grégoire;Oncologist,2007

Cited by 526 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interconnected influences of tumour and host microbiota on treatment response and side effects in nasopharyngeal cancer;Critical Reviews in Oncology/Hematology;2024-10

2. Short-term OS as a surrogate endpoint for 5-year OS in nasopharyngeal carcinoma in non-endemic area;World Journal of Surgical Oncology;2024-07-11

3. Global trends in research of nasopharyngeal carcinoma: a bibliometric and visualization analysis;Frontiers in Oncology;2024-07-02

4. Efficacy of metastatic lesion radiotherapy in patients with metastatic nasopharyngeal carcinoma: A multicenter retrospective study;Radiotherapy and Oncology;2024-07

5. Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer;Radiotherapy and Oncology;2024-07